Receptors, Purinergic P2Y12
"Receptors, Purinergic P2Y12" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of purinergic P2Y receptors that have a preference for ADP binding and are coupled to GTP-BINDING PROTEIN ALPHA SUBUNIT, GI. The P2Y12 purinergic receptors are found in PLATELETS where they play an important role regulating PLATELET ACTIVATION.
| Descriptor ID |
D058925
|
| MeSH Number(s) |
D12.776.543.750.695.700.720.500.300 D12.776.543.750.720.700.720.750.300
|
| Concept/Terms |
Receptors, Purinergic P2Y12- Receptors, Purinergic P2Y12
- P2Y12 Receptors, Purinergic
- Purinergic P2Y12 Receptors
- Purinergic Receptor P2Y, G-Protein Coupled, 12
- Purinoceptor P2Y12
- P2Y12, Purinoceptor
- P2Y12 Purinoceptors
- Purinoceptors, P2Y12
- P2Y(ADP) Receptor
- P2Y(T) Receptor
- P2Y12 Purinoceptor
- Purinoceptor, P2Y12
- Purinoceptor P2T
- P2T, Purinoceptor
- Purinergic Receptor P2Y12
- P2Y12, Purinergic Receptor
- P2T Purinoceptor
- Purinoceptor, P2T
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Purinergic P2Y12".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Purinergic [D12.776.543.750.695.700]
- Receptors, Purinergic P2 [D12.776.543.750.695.700.720]
- Receptors, Purinergic P2Y [D12.776.543.750.695.700.720.500]
- Receptors, Purinergic P2Y12 [D12.776.543.750.695.700.720.500.300]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Purinergic [D12.776.543.750.720.700]
- Receptors, Purinergic P2 [D12.776.543.750.720.700.720]
- Receptors, Purinergic P2Y [D12.776.543.750.720.700.720.750]
- Receptors, Purinergic P2Y12 [D12.776.543.750.720.700.720.750.300]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Purinergic P2Y12".
This graph shows the total number of publications written about "Receptors, Purinergic P2Y12" by people in this website by year, and whether "Receptors, Purinergic P2Y12" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Purinergic P2Y12" by people in Profiles.
-
Switching Between Intravenous and Oral P2Y12 Inhibition: Easier Said Than Done. JACC Cardiovasc Interv. 2023 01 09; 16(1):47-49.
-
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation. Eur J Pharmacol. 2019 Nov 05; 862:172627.
-
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. JACC Cardiovasc Interv. 2016 05 23; 9(10):1036-46.
-
Influences of hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model. J Cardiothorac Vasc Anesth. 2013 Dec; 27(6):e69-71.
-
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost. 2013 Jul; 110(1):118-23.
-
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. JACC Cardiovasc Imaging. 2012 May; 5(5):540-9.